STIM is Neuronetics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.77. Market cap: $216M. Capital Quality Rank: 39/100 — Stagnant mediocrity.
Stock snapshot
| Price | $2.77 |
| Market cap | $216M |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 39 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -38.9% |
| Revenue CAGR (3y) | 31.8% |
| Shareholder buyback yield | -30.00% |
| Altman Z-score zone | Distress |
About STIM
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Related non-dividend companies
Other non-dividend stocks investors research alongside STIM. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is STIM's current stock price?
STIM (Neuronetics, Inc.) is currently trading at $2.77.
Does STIM pay a dividend?
STIM (Neuronetics, Inc.) does not currently pay a regular dividend.
What is STIM's Capital Quality Rank?
STIM has a Capital Quality Rank of 39/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track STIM in DiviDrip
Add STIM to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search STIM and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.